Ensemble 2 (COVID-19 Vaccine) Study
COVID-19 is a disease caused by a virus called Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This virus is usually passed from person to person by small droplets from the nose or mouth when an infected person coughs, sneezes, or speaks.
Most people who have the virus either have mild symptoms such as a cough, fever and extreme tiredness and others do not have any symptoms at all. But some people have severe symptoms and can die.
This study is being done to test a new vaccine called Ad26.COV2.S. Doctors and scientists hope that the study vaccine could stop or reduce how seriously people are affected by COVID-19. Our bodies fight disease, viruses and infection through our immune systems. Vaccines work by teaching our immune systems how to protect us from a specific virus.
The main aims of this study are to find out:
1. If the study vaccine helps to reduce how seriously people are affected by COVID-19.
2. If the study vaccine is safe for humans.
3. To learn more about any side effects the study vaccine may cause.
The study involves up to 30,000 people around the world. Everyone who takes part will receive two injections in their arm, around 2 months apart. Some people taking part will be given two injections of the study vaccine, and others will receive two injections of placebo.
Some other assessments are required including saliva and blood samples.
The team have had a tremendous response from people interested in helping with this study so far. As the virus affects the BAME (Black, Asian and Minority Ethnic) population disproportionately they are now particularly keen to hear from people from a Black Asian and Minority Ethnic background.
For more information about this study please email [email protected].
If you are interested in taking part in this study, please complete the short questionnaire below and please ensure that you register with SHARE on completion (even if you have done so already) so that we can contact you.